PMID- 16155211 OWN - NLM STAT- MEDLINE DCOM- 20060119 LR - 20131121 IS - 0026-895X (Print) IS - 0026-895X (Linking) VI - 68 IP - 6 DP - 2005 Dec TI - Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger. PG - 1803-9 AB - Hypoxia-induced gene expression is initiated when the hypoxia-inducible factor-1 (HIF-1) alpha subunit is stabilized in response to a lack of oxygen. An HIF-1alpha-specific prolyl-hydroxylase (PHD) catalyzes hydroxylation of the proline-564 and/or -402 residues of HIF-1alpha by an oxygen molecule. The hydroxyproline then interacts with the ubiquitin E3 ligase von Hippel Lindau protein and is degraded by an ubiquitin-dependent proteasome. PHD2 is the most active of three PHD isoforms in hydroxylating HIF-1alpha. Structural analysis showed that the N-terminal region of PHD2 contains a Myeloid translocation protein 8, Nervy, and DEAF1 (MYND)-type zinc finger domain, whereas the catalytic domain is located in its C-terminal region. We found that deletion of the MYND domain increased the activity of both recombinant PHD2 protein and in vitro-translated PHD2. The zinc chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine augmented the activity of wild-type PHD2-F but not that of PHD2 lacking the MYND domain, confirming that the zinc finger domain is inhibitory. Overexpression of PHD2 lacking the MYND domain caused a greater reduction in the stability and function of HIF-1alpha than did overexpression of wild-type PHD2, indicating that the MYND domain also inhibits the catalytic activity of PHD2 in vivo. FAU - Choi, Kyung-Ok AU - Choi KO AD - Department of Life Science, University of Seoul, 90 Cheonnong-dong, Tongdaemun-gu, Seoul 130-743, Korea. FAU - Lee, Taekyong AU - Lee T FAU - Lee, Naery AU - Lee N FAU - Kim, Ji-Hyun AU - Kim JH FAU - Yang, Eun Gyeong AU - Yang EG FAU - Yoon, Jung Min AU - Yoon JM FAU - Kim, Jin Hwan AU - Kim JH FAU - Lee, Tae Gyu AU - Lee TG FAU - Park, Hyunsung AU - Park H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050909 PL - United States TA - Mol Pharmacol JT - Molecular pharmacology JID - 0035623 RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Immediate-Early Proteins) RN - EC 1.14.11.2 (EGLN1 protein, human) RN - EC 1.14.11.2 (Procollagen-Proline Dioxygenase) RN - EC 1.14.11.29 (Hypoxia-Inducible Factor-Proline Dioxygenases) RN - S88TT14065 (Oxygen) SB - IM MH - Catalytic Domain MH - HeLa Cells MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/metabolism MH - Hypoxia-Inducible Factor-Proline Dioxygenases MH - Immediate-Early Proteins/*antagonists & inhibitors/chemistry/genetics MH - Mutagenesis MH - Oxygen/pharmacology MH - Procollagen-Proline Dioxygenase/*antagonists & inhibitors/chemistry/genetics MH - Protein Structure, Tertiary MH - Sequence Deletion MH - Transfection MH - Zinc Fingers/*physiology EDAT- 2005/09/13 09:00 MHDA- 2006/01/20 09:00 CRDT- 2005/09/13 09:00 PHST- 2005/09/13 09:00 [pubmed] PHST- 2006/01/20 09:00 [medline] PHST- 2005/09/13 09:00 [entrez] AID - mol.105.015271 [pii] AID - 10.1124/mol.105.015271 [doi] PST - ppublish SO - Mol Pharmacol. 2005 Dec;68(6):1803-9. doi: 10.1124/mol.105.015271. Epub 2005 Sep 9.